Indrayani Biotech Board Approves Demerger Evaluation and Appoints Internal Auditor
The Board of Directors of Indrayani Biotech Ltd conducted its meeting on April 9, 2026, deliberating on key corporate restructuring and appointment matters.The Board discussed and passed resolutions regarding the company's food division. It gave its approval to explore and further evaluate a preliminary proposal for the demerger of the food division into a separate entity.
To guide this process, the Board approved the constitution of a "Restructuring Committee." This committee is tasked with overseeing the demerger process, making necessary decisions, and initiating required actions. Furthermore, the Committee received authorization to appoint various experts. These experts include legal counsel, tax advisors, and merchant bankers, who will provide professional opinions, feasibility reports, and an analysis detailing the pros and cons of the proposed demerger.
In another resolution, the Board approved the appointment of M/S VAITHIANATHAN & ASSOCIATES, Chartered Accountants, to serve as the Internal Auditor for the Company for the Financial Year 2025-26 and the Financial Year 2026-27.
The board meeting began at 4:45 PM and concluded at 5:50 PM.
Stock Price Movement
Indrayani Biotech Ltd shares settled at ₹10.89 on Thursday, marking a considerable rise of 6.76%. Throughout the session, the shares experienced movement, finding themselves between an intraday low of ₹10.20 and a peak of ₹11.30.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.